The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology [13]

Hepatology

Volumn 47, Issue 1, 2008, Pages 361-362

  Ballestri, Stefano ^a   Lonardo, Amedeo ^a   Carulli, Lucia ^a   Ricchi, Matteo ^a   Bertozzi, Lorena ^a   De Santis, Giorgio ^b   Bondi, Mario ^a   Loria, Paola ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL ABUSE; BODY FAT DISTRIBUTION; CASE REPORT; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LETTER; LIPOMATOSIS; LIVER; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

BODY FAT DISTRIBUTION; FATTY LIVER; HUMANS; LIPOMATOSIS, MULTIPLE SYMMETRICAL; LIVER; MALE; MIDDLE AGED;

EID: 38649085625     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21977     Document Type: Letter

References (10)

1. Cheung O, Kapoor A, Puri P, Sistrun S, Luketic VA, Sargeant CC, et al. The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. HEPATOLOGY 2007. DOI: 10.1002/hep.21803.
2. Madelung OW: Über den Fetthals (diffuses Lipom des Halses). Langenbecks Arch Klin Chir 1888;37:106-130.
3. Enzi G, Busetto L, Ceschin E, Coin A, Digito M, Pigozzo S. Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study. Int J Obes Relat Metab Disord 2002;26:253-261.
4. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet 1998;351:867-870.
5. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, et al. Risk factors of fibrosis in alcohol-induced liver disease. HEPATOLOGY 2002;35:635-638.
6. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438.
7. Nielsen S, Levine J, Clay R, Jensen MD. Adipose tissue metabolism in benign symmetric lipomatosis. J Clin Endocrinol Metab 2001;86:2717-2720.
8. Lonardo A, Bagni A, Tarugi P, Loria P. The wide spectrum of steatohepatitis: a report of four cases and a review of the literature. Eur J Gastroenterol Hepatol 2004;16:1043-1050.
9. Lonardo A, Carani C, Carulli N, Loria P. 'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol 2006;44:1196-1207.
10. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. HEPATOLOGY 2007;45:1366-1374.